Trial Profile
Assessing feasibility, safety and efficacy of IVIg therapy in patients with acute traumatic spinal cord injury
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- Acronyms INFUSE Trial
- 10 Jul 2017 New trial record